New cancer drug trial targets genetic weaknesses in tumors

NCT ID NCT05787587

Recruiting now Disease control Sponsor: IDEAYA Biosciences Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing a new drug called IDE161, both alone and combined with an existing immunotherapy (pembrolizumab), for people with advanced solid tumors that have spread. The main goals are to find safe doses and see if the treatment shows early signs of shrinking tumors. It is for adults with specific cancers like breast, ovarian, or endometrial cancer who have already tried standard treatments.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

California Pacific Medical Center
WITHDRAWN

San Francisco, California, 94115, United States
Columbia University Medical Center
COMPLETED

New York, New York, 10032, United States
Comprehensive Cancer Centers of Nevada
ACTIVE_NOT_RECRUITING

Las Vegas, Nevada, 89169, United States
Dana Faber Cancer Institute
RECRUITING

Boston, Massachusetts, 02215, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Emory University
ACTIVE_NOT_RECRUITING

Atlanta, Georgia, 30322, United States
Hoag Memorial Hospital
ACTIVE_NOT_RECRUITING

Newport Beach, California, 92663, United States
HonorHealth Research Institute
WITHDRAWN

Phoenix, Arizona, 85027, United States
Indiana University
COMPLETED

Indianapolis, Indiana, 46202, United States
Karmanos Cancer Institute
RECRUITING

Detroit, Michigan, 48201, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••
MD Anderson
RECRUITING

Houston, Texas, 77030, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••
NEXT Oncology
RECRUITING

Irving, Texas, 75039, United States

Contact Phone: •••-•••-••••
NEXT Oncology
RECRUITING

San Antonio, Texas, 78229, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
NEXT Oncology
RECRUITING

Fairfax, Virginia, 22031, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••
OSF St Francis Medical Center
WITHDRAWN

Peoria, Illinois, 61637, United States
Orlando Health
WITHDRAWN

Orlando, Florida, 32806, United States
Roswell Park Comprehensive Cancer Center
COMPLETED

Buffalo, New York, 14203, United States
START Mountain Region
RECRUITING

West Valley City, Utah, 84119, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••
Sarah Cannon Research Institute
RECRUITING

Denver, Colorado, 80218, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••
Sarah Cannon Research Institute
RECRUITING

Nashville, Tennessee, 37203, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••
Sarah Cannon Research Institute - Oklahoma University
RECRUITING

Oklahoma City, Oklahoma, 73104, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Sarah Cannon Research Institute - Thomas Jefferson University
RECRUITING

Philadelphia, Pennsylvania, 19107, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Swedish Cancer Institute
RECRUITING

Seattle, Washington, 98104, United States

Contact Email: •••••@•••••
The Angeles Clinic
RECRUITING

Los Angeles, California, 90025, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
University of Pennsylvania
ACTIVE_NOT_RECRUITING

Philadelphia, Pennsylvania, 19104, United States
University of Wisconsin
RECRUITING

Madison, Wisconsin, 53792, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Weil Cornell University
RECRUITING

New York, New York, 10065, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••
Yale University
RECRUITING

New Haven, Connecticut, 06511, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ADVANCED OR METASTATIC SOLID TUMORS BREAST CANCER COLORECTAL CANCER ENDOMETRIAL CANCER EXTENSIVE-STAGE SMALL CELL LUNG CANCER (ES-SCLC) HEAD AND NECK CANCERS NSCLC OVARIAN CANCER PROSTATE CANCER